Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2015

01.12.2015 | Clinical Case Report

A negative waveform in the scotopic response in a patient with phosphoglycerate kinase deficiency: a visual electrophysiology report

verfasst von: Safinaz Mohd Khialdin, John Grigg, Neil Rowe, Stephanie Crofts, Meredith Wilson, Christopher Troedson

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Phosphoglycerate kinase (PGK) deficiency is an X-linked neurometabolic genetic disorder with variable systemic manifestations. So far, only one patient with retinal anomalies has been reported, but no visual electrophysiology findings were described. We report the first description of visual electrophysiology in a child with PGK deficiency. This provides further information for the site of involvement in the eye.

Method

A case history of a nine-year-old boy with PGK deficiency is reported.

Results

This patient was diagnosed with PGK deficiency by screening soon after birth, as his mother was a known carrier of a PGK gene mutation. A bone marrow transplant was performed at the age of 9 months. He had two episodes of encephalopathy following the transplant but no acute episode of haemolysis. From the age of 6 years, his vision has been deteriorating. Visual electrophysiology results identified retinal involvement involving both rod and cone dysfunction. The visual evoked potential was normal.

Conclusions

Retinal dystrophy may be one of the clinical manifestations of phosphoglycerate kinase deficiency.
Literatur
1.
Zurück zum Zitat Chen SH, Malcolm LA, Yoshida A, Giblett E (1971) Phosphoglycerate kinase: an X-linked polymorphism in man. Am J Hum Genet 23:87–91PubMedCentralPubMed Chen SH, Malcolm LA, Yoshida A, Giblett E (1971) Phosphoglycerate kinase: an X-linked polymorphism in man. Am J Hum Genet 23:87–91PubMedCentralPubMed
2.
Zurück zum Zitat Willard HF, Goss SJ, Holmes MT, Munroe DL (1985) Regional localization of the phosphoglycerate kinase gene and pseudogene on the human X chromosome and assignment of a related DNA sequence to chromosome 19. Hum Genet 71:138–143CrossRefPubMed Willard HF, Goss SJ, Holmes MT, Munroe DL (1985) Regional localization of the phosphoglycerate kinase gene and pseudogene on the human X chromosome and assignment of a related DNA sequence to chromosome 19. Hum Genet 71:138–143CrossRefPubMed
3.
Zurück zum Zitat Turner G, Fletcher J, Elber J, Yanagawa Y, Dave V, Yoshida A (1995) Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in large kindred. Br J Haematol 91:60–65CrossRefPubMed Turner G, Fletcher J, Elber J, Yanagawa Y, Dave V, Yoshida A (1995) Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in large kindred. Br J Haematol 91:60–65CrossRefPubMed
4.
Zurück zum Zitat Morimoto A, Ueda I, Hirashima Y, Sawai Y, Usuku T, Kano G, Kuriyama K, Todo S, Sugimoto T, Kanno H, Fujii H, Imashuku S (2003) A novel missense mutation (1060G→C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis. Br J Haematol 122:10009–11013CrossRef Morimoto A, Ueda I, Hirashima Y, Sawai Y, Usuku T, Kano G, Kuriyama K, Todo S, Sugimoto T, Kanno H, Fujii H, Imashuku S (2003) A novel missense mutation (1060G→C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis. Br J Haematol 122:10009–11013CrossRef
5.
Zurück zum Zitat Flanagan JM, Rhodes M, Wilson M, Beutler E (2006) The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Brit J Haematol 134:233–237CrossRef Flanagan JM, Rhodes M, Wilson M, Beutler E (2006) The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Brit J Haematol 134:233–237CrossRef
6.
Zurück zum Zitat Rhodes M, Ashford L, Manes B, Calder C, Domm J, Frangoul H (2011) Bone marrow transplantation in phosphoglycerate (PGK) deficiency. Br J Haematol 152:500–502CrossRefPubMed Rhodes M, Ashford L, Manes B, Calder C, Domm J, Frangoul H (2011) Bone marrow transplantation in phosphoglycerate (PGK) deficiency. Br J Haematol 152:500–502CrossRefPubMed
8.
Zurück zum Zitat Meredith SP, Reddy MA, Allen LE, Moore AT, Bradshaw K (2004) Full-field ERG responses recorded with skin electrodes in paediatric patients with retinal dystrophy. Doc Ophthalmol 109:57–66CrossRefPubMed Meredith SP, Reddy MA, Allen LE, Moore AT, Bradshaw K (2004) Full-field ERG responses recorded with skin electrodes in paediatric patients with retinal dystrophy. Doc Ophthalmol 109:57–66CrossRefPubMed
9.
Zurück zum Zitat Kriss A, Jeffrey B, Taylor D (1992) The electroretinogram in infants and young children. J Clin Neurophysiol 9(3):373–393CrossRefPubMed Kriss A, Jeffrey B, Taylor D (1992) The electroretinogram in infants and young children. J Clin Neurophysiol 9(3):373–393CrossRefPubMed
11.
Zurück zum Zitat Cohen-Solal M, Valentin C, Plassa F, Guillemin G, Fanze F, Jaisson F, Rosa R (1994) Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Créteil and PGK Amiens. Blood 84(3):898–903PubMed Cohen-Solal M, Valentin C, Plassa F, Guillemin G, Fanze F, Jaisson F, Rosa R (1994) Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Créteil and PGK Amiens. Blood 84(3):898–903PubMed
12.
Zurück zum Zitat Noel N, Flanagan J, Kalko SG, Bajo MJR, Manu MDM, Fuster JLG, Beutler E, Corrons JLV (2005) Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. B J Haematol 132:523–529 Noel N, Flanagan J, Kalko SG, Bajo MJR, Manu MDM, Fuster JLG, Beutler E, Corrons JLV (2005) Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. B J Haematol 132:523–529
13.
Zurück zum Zitat Valentine WN, Hsieh HS, Paglia DE, Anderson HM, Baughan MA, Jaffé ER, Garson OM (1969) Hereditary haemolytic anaemia associated with phosphoglycerate kinase deficiency in erythrocytes and leucocytes. N Engl J Med 280(10):528–534CrossRefPubMed Valentine WN, Hsieh HS, Paglia DE, Anderson HM, Baughan MA, Jaffé ER, Garson OM (1969) Hereditary haemolytic anaemia associated with phosphoglycerate kinase deficiency in erythrocytes and leucocytes. N Engl J Med 280(10):528–534CrossRefPubMed
14.
Zurück zum Zitat Walters PT (1959) Anaerobic glycolysis in rats affected with retinitis pigmentosa. B J Ophthal 43:686–696CrossRef Walters PT (1959) Anaerobic glycolysis in rats affected with retinitis pigmentosa. B J Ophthal 43:686–696CrossRef
15.
Zurück zum Zitat Wrinkler BS (1981) Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol 77:667–692CrossRef Wrinkler BS (1981) Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol 77:667–692CrossRef
16.
Zurück zum Zitat Hedge KR, Kovtun S, Varma SD (2010) Inhibition of glycolysis in the retina by oxidative stress: prevention by pyruvate. Mol Cell Biochem 343:101–105CrossRef Hedge KR, Kovtun S, Varma SD (2010) Inhibition of glycolysis in the retina by oxidative stress: prevention by pyruvate. Mol Cell Biochem 343:101–105CrossRef
17.
Zurück zum Zitat Estrada-Sánchez AM, Montiel T, Massieu L (2010) Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 huntington’s disease mice. Neurochem Res 35:1156–1163CrossRefPubMed Estrada-Sánchez AM, Montiel T, Massieu L (2010) Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 huntington’s disease mice. Neurochem Res 35:1156–1163CrossRefPubMed
18.
Zurück zum Zitat Harada T, Harada C, Watanabe M et al (1998) Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci USA 95:4663–4666PubMedCentralCrossRefPubMed Harada T, Harada C, Watanabe M et al (1998) Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci USA 95:4663–4666PubMedCentralCrossRefPubMed
Metadaten
Titel
A negative waveform in the scotopic response in a patient with phosphoglycerate kinase deficiency: a visual electrophysiology report
verfasst von
Safinaz Mohd Khialdin
John Grigg
Neil Rowe
Stephanie Crofts
Meredith Wilson
Christopher Troedson
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2015
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-015-9511-0

Weitere Artikel der Ausgabe 3/2015

Documenta Ophthalmologica 3/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.